Molecular Partners AG MLLCF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.16M | -16.77M | -15.83M | -14.79M | -24.73M |
| Total Depreciation and Amortization | 612.60K | 639.20K | 583.30K | 658.80K | 670.40K |
| Total Amortization of Deferred Charges | -- | -- | 57.60K | -- | -- |
| Total Other Non-Cash Items | 944.20K | 1.15M | 1.51M | 1.22M | 3.56M |
| Change in Net Operating Assets | 1.94M | -3.19M | -280.40K | 510.00K | 4.61M |
| Cash from Operations | -13.66M | -18.17M | -13.96M | -12.41M | -15.88M |
| Capital Expenditure | -25.30K | -- | -174.00K | -38.80K | -116.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.26M | -5.01M | 15.13M | 13.37M | 18.26M |
| Cash from Investing | 18.23M | -5.01M | 14.96M | 13.33M | 18.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -301.00K | -300.00K | -300.00K | -305.00K | -304.00K |
| Issuance of Common Stock | 91.00K | 8.00K | 0.00 | 1.00K | 61.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -265.80K | -372.50K | -375.50K | -380.00K | -294.60K |
| Foreign Exchange rate Adjustments | 353.10K | 77.80K | -256.60K | -65.00K | -1.24M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -2.50K | 2.50K | -- |
| Net Change in Cash | 4.66M | -23.48M | 368.00K | 480.00K | 732.20K |